Entera Bio Management

Management criteria checks 2/4

Entera Bio's CEO is Miranda Toledano, appointed in Jul 2022, has a tenure of 2.33 years. total yearly compensation is $950.00K, comprised of 35.6% salary and 64.4% bonuses, including company stock and options. directly owns 0.3% of the company’s shares, worth €178.49K. The average tenure of the management team and the board of directors is 2.3 years and 5.6 years respectively.

Key information

Miranda Toledano

Chief executive officer

US$950.0k

Total compensation

CEO salary percentage35.6%
CEO tenure2.3yrs
CEO ownership0.3%
Management average tenure2.3yrs
Board average tenure5.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Miranda Toledano's remuneration changed compared to Entera Bio's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-US$9m

Mar 31 2024n/an/a

-US$9m

Dec 31 2023US$950kUS$338k

-US$9m

Sep 30 2023n/an/a

-US$10m

Jun 30 2023n/an/a

-US$11m

Mar 31 2023n/an/a

-US$11m

Dec 31 2022US$795kUS$231k

-US$13m

Sep 30 2022n/an/a

-US$14m

Jun 30 2022n/an/a

-US$14m

Mar 31 2022n/an/a

-US$14m

Dec 31 2021US$82kn/a

-US$12m

Compensation vs Market: Miranda's total compensation ($USD950.00K) is above average for companies of similar size in the German market ($USD483.75K).

Compensation vs Earnings: Miranda's compensation has increased whilst the company is unprofitable.


CEO

Miranda Toledano (47 yo)

2.3yrs

Tenure

US$950,000

Compensation

Ms. Miranda J. Toledano, M.B.A. serves as Chief Executive Officer of Entera Bio Ltd. since July 15, 2022. She serves as an Independent Director of Journey Medical Corporation since November 2021.She has b...


Leadership Team

NamePositionTenureCompensationOwnership
Miranda Toledano
CEO & Director2.3yrsUS$950.00k0.30%
€ 178.5k
Dana Yaacov-Garbeli
Chief Financial Officer2.3yrsUS$311.00k0.16%
€ 91.2k
Hillel Galitzer
Chief Operating Officer10.8yrsUS$459.00k0.094%
€ 55.0k
Gregory Burshtein
Chief of Research & Developmentless than a yearno data0.14%
€ 80.6k

2.3yrs

Average Tenure

46.5yo

Average Age

Experienced Management: 5DT's management team is considered experienced (2.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Miranda Toledano
CEO & Director6.2yrsUS$950.00k0.30%
€ 178.5k
Steven Goldstein
Member of Clinical & Scientific Advisory Board1.6yrsno datano data
Gerald Lieberman
Independent Chairman of the Board10.6yrsUS$130.97k0.80%
€ 467.8k
Gerald Ostrov
Independent Director5.8yrsUS$120.97k0.11%
€ 62.7k
Sofia Ish-Shalom
Member of Scientific Advisory Boardno datano datano data
Yonatan Malca
Independent Director13.8yrsUS$124.97k0.11%
€ 62.9k
Haya Taitel
Independent Director1.4yrsUS$8.61k0.16%
€ 93.0k
Sean Ellis
Independent Director5.4yrsUS$117.47k0.35%
€ 205.7k
Socrates Papapoulos
Member of Scientific Advisory Boardno datano datano data
John Bilezikian
Member of Scientific Advisory Boardno datano datano data
Felicia Cosman
Member of Scientific Advisory Board2yrsno datano data
William Fraser
Member of Scientific Advisory Boardno datano datano data

5.6yrs

Average Tenure

61yo

Average Age

Experienced Board: 5DT's board of directors are considered experienced (5.6 years average tenure).